
ASND, GDS, ADSK and CDZI among after hours movers
15.18BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
DK0060615755
CUSIP
04351P101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
17.63
PEG Ratio
-
Book Value
24.89
Dividend Share
-
Dividend Yield
-
Earnings Share
12.8
Wall Street Target Price
310.26
EPS Estimate Current Year
12.79
EPS Estimate Next Year
9.62
EPS Estimate Current Quarter
0.7667
EPS Estimate Next Quarter
1.3167
Most Recent Quarter
-
Revenue TTM
1,047,020,032
Gross Profit TTM
955,894,976
EBITDA
263,454,000
Profit Margin
70.85%
Return On Assets TTM
9.58%
Return On Equity TTM
118.78%
Revenue Per Share TTM
16.889
Qtly Revenue Growth YOY
114.70%
Diluted Eps TTM
12.8
Qtly Earnings Growth YOY
0.00%
Trailing PE
17.63
Forward PE
19
Price Sales TTM
14.1743
Price Book MRQ
8.9131
Enterprise Value Revenue
11
Enterprise Value EBITDA
65
205.88
3.03%122.52
1.52%197.82
1.30%527.40
0.95%1010.26
0.00%121.55
-5.41%235.66
-3.37%788.04
-0.96%31.24
-0.64%959.49
-0.18%Profit.com is operated by Darqube Ltd, registered in England and Wales under company number 12197411.
Profit.com is an educational, subscription-based software platform providing financial market analytics and simulated trading using real-time market data and virtual funds. All trading activity on the platform is simulated. No real capital is used, no customer deposits are collected, and no real-money trades are executed or facilitated.
Profit.com is not a broker and does not provide brokerage, investment, or other financial services or investment advice. All content, tools and features are provided for educational and informational purposes only. Simulated trading results are hypothetical and are not indicative of actual or future results. The terms “trading” and “trader” refer exclusively to simulated activity on Profit.com and should not be interpreted as real-money trading or investing.